GLUE icon

Monte Rosa Therapeutics
GLUE

Overview Fund Activity

105 hedge funds and large institutions have $276M invested in Monte Rosa Therapeutics in 2025 Q1 according to their latest regulatory filings, with 23 funds opening new positions, 22 increasing their positions, 44 reducing their positions, and 21 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
105
Holders Change
+1
Holders Change %
+0.96%
% of All Funds
1.43%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.04%
New
23
Increased
22
Reduced
44
Closed
21
Calls
$413K
Puts
$206K
Net Calls
+$207K
Net Calls Change
-$1.84M

Top Buyers

1
BI
BVF Inc
California
$26.3M
2
PL
Parkwood LLC
Ohio
$3.29M
3
ACA
Avoro Capital Advisors
New York
$21.6M
4
RAM
Readystate Asset Management
Illinois
$1.33M
5
Millennium Management
Millennium Management
New York
$1.53M

Top Sellers

1
Morgan Stanley
Morgan Stanley
New York
$1.96M
2
Citadel Advisors
Citadel Advisors
Florida
$0
3
Fidelity Investments
Fidelity Investments
Massachusetts
$21.7M
4
VPC
Vestal Point Capital
New York
$0
5
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
$30.8M
Name Holding Trade Value Shares
Change 		Shares
Change %
Wellington Management Group
26
Wellington Management Group
Massachusetts
$871K -$158K -34,010 -15%
TD Asset Management
27
TD Asset Management
Ontario, Canada
$798K -$223K -48,018 -22%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$762K -$28.6K -6,167 -4%
Renaissance Technologies
29
Renaissance Technologies
New York
$761K -$379K -81,600 -33%
IC
30
Ikarian Capital
Texas
$634K -$812K -175,000 -56%
NL
31
Nuveen LLC
North Carolina
$546K +$546K +117,672 New
Manulife (Manufacturers Life Insurance)
32
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$544K -$487 -105 -0.1%
American Century Companies
33
American Century Companies
Missouri
$466K +$109K +23,556 +31%
ECM
34
ExodusPoint Capital Management
New York
$447K +$447K +96,345 New
UBS Group
35
UBS Group
Switzerland
$425K +$149K +32,115 +54%
CC
36
Casdin Capital
New York
$399K – – –
RhumbLine Advisers
37
RhumbLine Advisers
Massachusetts
$289K +$2.08K +448 +0.7%
Susquehanna International Group
38
Susquehanna International Group
Pennsylvania
$247K +$152K +32,816 +160%
Verition Fund Management
39
Verition Fund Management
Connecticut
$240K +$240K +51,725 New
Qube Research & Technologies (QRT)
40
Qube Research & Technologies (QRT)
United Kingdom
$226K -$176K -37,847 -44%
Barclays
41
Barclays
United Kingdom
$214K -$114K -24,531 -35%
State of Wisconsin Investment Board
42
State of Wisconsin Investment Board
Wisconsin
$175K +$24.4K +5,253 +16%
BHCM
43
Brevan Howard Capital Management
Jersey
$174K +$174K +37,574 New
Invesco
44
Invesco
Georgia
$164K +$104K +22,499 +175%
BFM
45
Boothbay Fund Management
New York
$163K -$260K -56,122 -61%
AllianceBernstein
46
AllianceBernstein
Tennessee
$163K – – –
GCM
47
Graham Capital Management
Connecticut
$151K +$151K +32,586 New
Citigroup
48
Citigroup
New York
$144K -$63.9K -13,769 -31%
CC
49
Corton Capital
Ontario, Canada
$136K -$14K -3,018 -9%
Wells Fargo
50
Wells Fargo
California
$132K -$193K -41,607 -59%
1
2
3 4 5